Evidence map›Paper›PMID 35144725›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.

Samuel Alizon, Christian Selinger, Mircea T Sofonea, Stéphanie Haim-Boukobza, Jean-Marc Giannoli, Laetitia Ninove, Sylvie Pillet, Vincent Thibault, Alexis de Rougemont, Camille Tumiotto and 19 more

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 2 countries.

Samuel AlizonMIVEGEC, CNRS, IRD, Université de Montpellier, France.
Christian SelingerMIVEGEC, CNRS, IRD, Université de Montpellier, France.
Mircea T SofoneaMIVEGEC, CNRS, IRD, Université de Montpellier, France.
Stéphanie Haim-BoukobzaLaboratoire CERBA, Saint-Ouen-L'Aumône, France.
Jean-Marc GiannoliBIOGROUP, Scientific Direction, Lyon, France.
Laetitia NinoveUnité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
Sylvie PilletLaboratoire des agents infectieux et d'hygiène, CHU de Saint-Etienne, France.
Vincent ThibaultLaboratoire de Virologie, CHU Rennes, Rennes, France.
Alexis de RougemontUMR PAM A 02.102 Procédés Alimentaires et Microbiologiques, Université de Bourgogne Franche-Comté/AgroSup Dijon, Dijon, France.
Camille TumiottoUniversity of Bordeaux, CNRS-UMR 5234, CHU Bordeaux, Virology Department, Bordeaux, France.
Morgane SolisCHU de Strasbourg, Laboratoire de Virologie, Strasbourg, France, Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France.
Robin StephanLaboratoire de Microbiologie, CHU Nîmes, Nîmes, France.
Céline Bressollette-BodinCHU Nantes, Nantes Université, Service de Virologie, Nantes, France.
Maud SalmonaLaboratoire de Virologie, Hôpital Saint Louis, APHP, INSERM U976, équipe INSIGHT, Université de Paris, Paris, France.
Anne-Sophie L'HonneurAssistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Virologie, Paris, France.
Sylvie BehillilNational Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, UMR 3569 CNRS, University of Paris, Institut Pasteur, Paris, France.
Caroline LefeuvreDépartement de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU d'Angers, Angers, France.
Julia DinaLaboratoire de Virologie, CHU de Caen, UNICAEN, INSERM U1311 DYNAMICURE, Université de Caen Normandie, Caen, France.
Sébastien HantzCHU Limoges, Laboratoire de Bactériologie-Virologie-Hygiène, Limoges, France.
Cédric HartardLaboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-lès-Nancy, France; Université de Lorraine, CNRS, LCPME, Nancy, France.
David VeyerLaboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris et Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France.
Héloïse M DelagrèverieAP-HP, Hôpital Avicenne, Laboratoire de microbiologie clinique, Bobigny, France.
Slim FouratiHenri Mondor Hospital, virology department, Créteil, France.
Benoît VisseauxUniversité de Paris, Inserm, UMR 1137 IAME et Laboratoire de Virologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Cécile HenquellService de Virologie médicale, 3IHP, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Bruno LinaCNR des virus des infections respiratoires (dont la Grippe), Institut des Agents Infectieux, Hopital de la Croix Rousse, HCL, Lyon, France.
Vincent FoulongnePathogenesis and control of chronic and emerging infections, Université de Montpellier, UMR 1058, CHU de Montpellier, Inserm, Université des Antilles, Montpellier, France.
Sonia BurrelSorbonne Université, INSERM U1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), AP-HP, Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
SFM COVID-19 study groupFrench Society of Microbiology (SFM), https://www.sfm-microbiologie.org.
Inserm · FRCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Limoges · FRCentre Hospitalier Universitaire de Nîmes · FRCentre Hospitalier Universitaire de Rennes · FRHôpital Cochin · FRHôpital de la Croix-Rousse · FRInstitut de Virologie · FRNantes Université · FRTwitter (United States) · USUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundThe COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases.AimWe explored the possibility to use Cq values from SARS-CoV-2 screening tests to better understand the spread of an epidemic and to better understand the biology of the infection.MethodsWe used linear regression models to analyse a large database of 793,479 Cq values from tests performed on more than 2 million samples between 21 January and 30 November 2020, i.e. the first two pandemic waves. We performed time series analysis using autoregressive integrated moving average (ARIMA) models to estimate whether Cq data information improves short-term predictions of epidemiological dynamics.ResultsAlthough we found that the Cq values varied depending on the testing laboratory or the assay used, we detected strong significant trends associated with patient age, number of days after symptoms onset or the state of the epidemic (the temporal reproduction number) at the time of the test. Furthermore, knowing the quartiles of the Cq distribution greatly reduced the error in predicting the temporal reproduction number of the COVID-19 epidemic.ConclusionOur results suggest that Cq values of screening tests performed in the general population generate testable hypotheses and help improve short-term predictions for epidemic surveillance.

Indexed as

COVID-19SARS-CoV-2FranceHumansPandemicsReverse Transcriptase Polymerase Chain ReactionCOVID-19epidemiologyRT-PCRSARS-CoV-2statistical modellingvirus load

Identifiers

PMID35144725
PMCPMC8832522
OpenAlexW4210949682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.